[Platelet adenosine desaminase in various hematological diseases]

Ia M Sokovnina, T I Pestina, A I Chizhova

Voprosy Meditsinskoi Khimii

|May 1, 1985

Abstract:

Activity of adenosine deaminase (EC 3.5.4.4) was studied in thrombocytes of donors and patients with various hematological diseases. The enzymatic activity was decreased in acute leukemia, chronic myeloleukemia, chronic leukemia and blast transformation myeloma, microspherocytic and hypoplastic anemias. Variable level of the activity was observed in chronic lympholeukemia and non-Hodgkin disease. In all the diseases studied functions of thrombocytes were altered after treatment with various aggregating agents (ADP, thrombin, collagen, adrenaline, ristomycin).

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

[Determination of the electrophoretic mobility of peripheral red blood cells from healthy individuals, by using ethylene-2-amine-4-chloroacetic acid as a preservative].

Klinicheskaia laboratornaia diagnostika·2009

The roles of ADP and TXA in botrocetin/VWF-induced aggregation of washed platelets.

Journal of thrombosis and haemostasis : JTH·2004

AlphaIIbbeta3-mediated outside-in signaling induced by the agonist peptide LSARLAF utilizes ADP and thromboxane A2 receptors to cause alpha-granule secretion by platelets.

Journal of thrombosis and haemostasis : JTH·2003

A schedule of recombinant Mpl ligand highly effective at preventing lethal myelosuppression in mice given carboplatin and radiation.

Experimental hematology·2001

Mpl ligand prevents lethal myelosuppression by inhibiting p53-dependent apoptosis.

Blood·2001

Role of the distal half of the c-Mpl intracellular domain in control of platelet production by thrombopoietin in vivo.

Molecular and cellular biology·1999

See all related articles

Related Experiment Videos

[Platelet adenosine desaminase in various hematological diseases]

Related Concept Videos

[Determination of the electrophoretic mobility of peripheral red blood cells from healthy individuals, by using ethylene-2-amine-4-chloroacetic acid as a preservative].

The roles of ADP and TXA in botrocetin/VWF-induced aggregation of washed platelets.

AlphaIIbbeta3-mediated outside-in signaling induced by the agonist peptide LSARLAF utilizes ADP and thromboxane A2 receptors to cause alpha-granule secretion by platelets.

A schedule of recombinant Mpl ligand highly effective at preventing lethal myelosuppression in mice given carboplatin and radiation.

Mpl ligand prevents lethal myelosuppression by inhibiting p53-dependent apoptosis.

Role of the distal half of the c-Mpl intracellular domain in control of platelet production by thrombopoietin in vivo.

[Study of functional activity of components and factors of the human complement system].

[Stability of immobilized insulin preparation at various pH].

[Characterization of cysteine proteinase endogenous inhibitors obtained from transformed fibroblasts].

[Isolation, purification, and properties of factor XII and its active fragment (beta-XIIa)].

[Inhibition by IFN-(Asp)4-Lys-HIV chimeric protein of hydrolysis of the low molecular substrate by the enteropeptidase light chain].

[Tripeptidyl peptidase 1 deficiency in neuronal ceroid lipofuscinosis. A novel mutation].

Related Experiment Videos

[Platelet adenosine desaminase in various hematological diseases]

Abstract:

Related Concept Videos

Related Articles